NDUFA9 and metabolic dysfunction-associated steatotic liver disease: We found significantly decreased expression of NDUFA9 and UQCRQ in the NAFLD model group compared to the control group, but no significant difference in the expression of NDUFB8 between NAFLD and control groups (Figure 6).